Related Experiment Video

Updated: Jul 11, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for

Nadia Stefanova1, Markus Reindl, Manuela Neumann

  • 1Clinical Neurobiology Unit, Neurodegeneration Research Laboratory, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Movement Disorders : Official Journal of the Movement Disorder Society
|September 14, 2007
PubMed

Insights

Microglial activation in the substantia nigra pars compacta (SNc) contributes to neurodegeneration in a mouse model of multiple system atrophy (MSA). Suppressing this inflammation protected dopamine neurons, suggesting a therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by alpha-synuclein aggregation and loss of dopaminergic neurons.
  • Microglial activation, a key component of neuroinflammation, is implicated in MSA pathogenesis but its precise role remains unclear.

Purpose of the Study:

  • To investigate the role of microglial activation in oligodendroglial alpha-synuclein-induced neurodegeneration in a transgenic mouse model of MSA.
  • To explore potential therapeutic strategies targeting neuroinflammation in MSA.

Main Methods:

  • Utilized a transgenic mouse model exhibiting oligodendroglial alpha-synuclein inclusions and dopaminergic neuron loss.
  • Employed histopathology and morphometric analysis to assess microglial activation and neuronal survival.
  • Administered minocycline, a microglial activation inhibitor, to evaluate its neuroprotective effects.

Main Results:

  • Demonstrated early, progressive microglial activation in the substantia nigra pars compacta (SNc) of transgenic mice.
  • Observed increased inducible nitric oxide synthase (iNOS) expression correlating with dopaminergic neuronal loss.
  • Showed that minocycline treatment significantly protected dopaminergic SNc neurons, suppressing microglial activation.
  • Detected increased toll-like receptor 4 (TLR4) immunoreactivity in both transgenic mice and human MSA brains.

Conclusions:

  • Oligodendroglial alpha-synuclein overexpression induces neuroinflammation and nitrosative stress, contributing to neurodegeneration in MSA.
  • Microglial activation in the SNc is a critical factor in MSA-related dopaminergic neuron loss.
  • Targeting microglial activation and potentially the TLR4 pathway represents a promising therapeutic strategy for MSA.

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...